KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Non-Current Debt (2021 - 2025)

Historic Non-Current Debt for Halozyme Therapeutics (HALO) over the last 6 years, with Q3 2025 value amounting to $800.1 million.

  • Halozyme Therapeutics' Non-Current Debt fell 4680.92% to $800.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $800.1 million, marking a year-over-year decrease of 4680.92%. This contributed to the annual value of $1.5 billion for FY2024, which is 43.69% up from last year.
  • Per Halozyme Therapeutics' latest filing, its Non-Current Debt stood at $800.1 million for Q3 2025, which was down 4680.92% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Halozyme Therapeutics' Non-Current Debt ranged from a high of $1.5 billion in Q2 2025 and a low of $787.3 million during Q4 2021
  • Its 5-year average for Non-Current Debt is $1.4 billion, with a median of $1.5 billion in 2023.
  • Per our database at Business Quant, Halozyme Therapeutics' Non-Current Debt soared by 8961.66% in 2022 and then crashed by 4680.92% in 2025.
  • Over the past 5 years, Halozyme Therapeutics' Non-Current Debt (Quarter) stood at $787.3 million in 2021, then surged by 89.62% to $1.5 billion in 2022, then increased by 0.43% to $1.5 billion in 2023, then grew by 0.44% to $1.5 billion in 2024, then crashed by 46.87% to $800.1 million in 2025.
  • Its Non-Current Debt was $800.1 million in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.5 billion in Q1 2025.